Diabetes, Vol 39, Issue 1 1-5, Copyright © 1990 by American Diabetes Association

ARTICLES

Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes

Y Shechter
Department of Hormone Research, Weizmann Institute of Science, Rehovot, Israel.

Vanadate ions, low-molecular-weight phosphate analogues, mimic most of the rapid actions of insulin in various cell types. When administered orally to diabetic hyperglycemic rats, vanadate reaches the circulation, mimics insulin stimulation of glucose uptake and metabolism, and leads to normoglycemic and partial anabolic states. In addition, vanadate restores tissue responsiveness to insulin and hepatic glycogen levels and activates new synthesis of key enzymes for carbohydrate metabolism. This suggests that correcting hyperglycemia is sufficient to correct the typical metabolic alterations found in streptozocin-induced diabetic rats. Several weeks of oral administration of vanadate to diabetic rats has not produced detectable liver or kidney toxicity. The mechanism by which vanadate mimics the actions of insulin is still obscure. Unlike insulin, vanadate does not seem to stimulate the autophosphorylation and endogenous tyrosine phosphorylation of insulin-receptor kinase or other intracellular proteins either directly or by virtue of its known inhibitory effect on protein phosphotyrosine phosphatase. Results from many studies support a model in which vanadate activates glucose metabolism by either utilizing an alternative (insulin-independent) cascade or bypassing the early events of the insulin-dependent cascade. Either of these possibilities is of clinical importance, because early insulin events may become defective, as a result of severe hyperinsulinemia, and may contribute to insulin resistance. Alternative pathways by which vanadate may stimulate glucose metabolism, e.g., by increasing intracellular Ca2+ levels and/or regulating intracellular and intravesicular pH, are discussed. From a clinical perspective, studies should be continued in evaluating the level of vanadate toxicity after prolonged treatment and searching for agents that potentiate its insulin mimetic actions in vitro and in vivo.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Kirchner, E. Kwon, A. Muduli, C. Cerqueira, X.-L. Cui, and R. P. Ferraris Vanadate but Not Tungstate Prevents the Fructose-Induced Increase in GLUT5 Expression and Fructose Uptake by Neonatal Rat Intestine J. Nutr., September 1, 2006; 136(9): 2308 - 2313. [Abstract] [Full Text] [PDF]

				Y. Hasegawa, M. Morioka, S. Hasegawa, J. Matsumoto, T. Kawano, Y. Kai, S. Yano, K. Fukunaga, and J.-i. Kuratsu Therapeutic Time Window and Dose Dependence of Neuroprotective Effects of Sodium Orthovanadate following Transient Middle Cerebral Artery Occlusion in Rats J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 875 - 881. [Abstract] [Full Text] [PDF]

				N. Ohi, Y. Nishikawa, T. Tokairin, Y. Yamamoto, Y. Doi, Y. Omori, and K. Enomoto Maintenance of Bad Phosphorylation Prevents Apoptosis of Rat Hepatic Sinusoidal Endothelial Cells in Vitro and in Vivo Am. J. Pathol., April 1, 2006; 168(4): 1097 - 1106. [Abstract] [Full Text] [PDF]

				L. A. Nolte, D.-H. Han, P. A. Hansen, K. A. Hucker, and J. O. Holloszy A Peroxovanadium Compound Stimulates Muscle Glucose Transport as Powerfully as Insulin and Contractions Combined Diabetes, August 1, 2003; 52(8): 1918 - 1925. [Abstract] [Full Text] [PDF]

				M.-D. Chen, V. C. Yang, P. S. Alexander, P.-Y. Lin, and Y.-M. Song Effects of Selected Minerals on Leptin Secretion in Streptozotocin-Induced Hyperglycemic Mice Experimental Biology and Medicine, October 1, 2001; 226(9): 836 - 840. [Abstract] [Full Text] [PDF]

				I. Goldwaser, S. Qian, E. Gershonov, M. Fridkin, and Y. Shechter Organic Vanadium Chelators Potentiate Vanadium-Evoked Glucose Metabolism In Vitro and In Vivo: Establishing Criteria for Optimal Chelators Mol. Pharmacol., October 1, 2000; 58(4): 738 - 746. [Abstract] [Full Text]

				Q. Sun, N. Sekar, I. Goldwaser, E. Gershonov, M. Fridkin, and Y. Shechter Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E403 - E410. [Abstract] [Full Text] [PDF]

				I. Goldwaser, J. Li, E. Gershonov, M. Armoni, E. Karnieli, M. Fridkin, and Y. Shechter L-Glutamic Acid gamma -Monohydroxamate. A POTENTIATOR OF VANADIUM-EVOKED GLUCOSE METABOLISM IN VITRO AND IN VIVO J. Biol. Chem., September 10, 1999; 274(37): 26617 - 26624. [Abstract] [Full Text] [PDF]

				N. Sekar, J. Li, Z. He, D. Gefel, and Y. Shechter Independent Signal-Transduction Pathways for Vanadate and for Insulin in the Activation of Glycogen Synthase and Glycogenesis in Rat Adipocytes Endocrinology, March 1, 1999; 140(3): 1125 - 1131. [Abstract] [Full Text]

				N. Sekar, S. Qian, and Y. Shechter Vanadate Elevates Lipogenicity of Starved Rat Adipose Tissue: Mechanism of Action Endocrinology, May 1, 1998; 139(5): 2514 - 2518. [Abstract] [Full Text] [PDF]

				I. A. Setyawati, K. H. Thompson, V. G. Yuen, Y. Sun, M. Battell, D. M. Lyster, C. Vo, T. J. Ruth, S. Zeisler, J. H. McNeill, et al. Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats J Appl Physiol, February 1, 1998; 84(2): 569 - 575. [Abstract] [Full Text] [PDF]

				S. Bortoli, M. Amessou, M. Collinet, B. Desbuquois, and S. Lopez Vanadate, But Not Insulin, Inhibits Insulin Receptor Gene Expression in Rat Hepatoma Cells Endocrinology, November 1, 1997; 138(11): 4821 - 4829. [Abstract] [Full Text] [PDF]

				J. Li, G. Elberg, N. Sekar, Z. B. He, and Y. Shechter Antilipolytic Actions of Vanadate and Insulin in Rat Adipocytes Mediated by Distinctly Different Mechanisms Endocrinology, June 1, 1997; 138(6): 2274 - 2279. [Abstract] [Full Text] [PDF]

				G. Huyer, S. Liu, J. Kelly, J. Moffat, P. Payette, B. Kennedy, G. Tsaprailis, M. J. Gresser, and C. Ramachandran Mechanism of Inhibition of Protein-tyrosine Phosphatases by Vanadate and Pervanadate J. Biol. Chem., January 10, 1997; 272(2): 843 - 851. [Abstract] [Full Text] [PDF]

				Z. Zhao, Z. Tan, C. D. Diltz, M. You, and E. H. Fischer Activation of Mitogen-activated Protein (MAP) Kinase Pathway by Pervanadate, a Potent Inhibitor of Tyrosine Phosphatases J. Biol. Chem., September 6, 1996; 271(36): 22251 - 22255. [Abstract] [Full Text] [PDF]

				B. Lu, D. Ennis, R. Lai, E. Bogdanovic, R. Nikolov, L. Salamon, C. Fantus, H. Le-Tien, and I. G. Fantus Enhanced Sensitivity of Insulin-resistant Adipocytes to Vanadate Is Associated with Oxidative Stress and Decreased Reduction of Vanadate (+5) to Vanadyl (+4) J. Biol. Chem., September 14, 2001; 276(38): 35589 - 35598. [Abstract] [Full Text] [PDF]